D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries

D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries

Name

 Western Governors University

D027 Advanced Pathopharmacological Foundations

Prof. Name

Date

D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries

Phase 1: Timeline and Estimated Completion

The initial phase outlines tasks with their proposed completion dates and estimated times for completion. These tasks focus on creating schedules, synthesizing pathophysiology, and reflecting on feedback through GoReact.

Task Description	Proposed Completion Date	Estimated Time to Complete
1a. CPE schedule table	June 10, 2024	30 minutes
1b. Feedback and Synthesis Improvement Plan	June 25, 2024	2 hours
1b. Pathophysiology Synthesis	June 25, 2024	2 hours
1c. Three screenshots of GoReact and reflection	June 25, 2024	1.5 hours

---

Phase 2: Timeline and Estimated Completion

Phase 2 tasks involve reviewing progress, improving synthesis based on feedback, and focusing on patient or healthcare consumer perspectives.

Task Description	Proposed Completion Date	Estimated Time to Complete
2a. Review CPE schedule table for progress	June 30, 2024	30 minutes
2b. Feedback and Synthesis Improvement Plan	June 30, 2024	2 hours
2b. Patient or Healthcare Consumer-Focused Synthesis	June 30, 2024	2 hours
2c. Three screenshots of GoReact and reflection	June 30, 2024	1.5 hours

---

Phase 3: Timeline and Estimated Completion

The final phase emphasizes continuous review and improvement of the synthesis and treatment plans, incorporating feedback and reflections.

Task Description	Proposed Completion Date	Estimated Time to Complete
3a. Review CPE schedule table for progress	July 4, 2024	30 minutes
3b. Feedback and Synthesis Improvement Plan	July 4, 2024	2 hours
3b. Preceptor or Colleague-Focused Synthesis	July 4, 2024	2 hours
3c. Feedback and Synthesis Improvement Plan	July 4, 2024	2 hours
3c. Patient or Healthcare Consumer-Focused Treatment Plan	July 4, 2024	2 hours
3d. Three screenshots of GoReact and reflection	July 4, 2024	2 hours

---

Phase 1.1B: Advanced Professional Nurse or Colleague Pathophysiology Synthesis

What is Chronic Lower Respiratory Infection, and What Are Its Pathophysiological Mechanisms?

Chronic lower respiratory infections refer to a spectrum of persistent lung diseases marked by inflammation and structural damage in the lower airways. These conditions result in ongoing respiratory symptoms and impaired lung function (World Health Organization [WHO], 2017). The pathophysiological basis varies among diseases:

• Chronic Obstructive Pulmonary Disease (COPD): Caused mainly by prolonged exposure to harmful agents such as tobacco smoke, COPD leads to chronic airway inflammation, bronchitis, and destruction of alveolar tissue (emphysema).
• Bronchiectasis: This condition is identified by permanent widening and damage of the bronchi due to repeated infections, impairing mucus clearance.
• Chronic Pneumonia: Involves persistent infection and inflammation caused by various pathogens, which results in continual lung tissue injury (Wheeldon, 2023).

What Are the Clinical Manifestations and Diagnostic Procedures?

Common clinical features in patients include:

• Persistent productive cough
• Wheezing and breathlessness
• Frequent respiratory infections
• Advanced stages may show weight loss, fatigue, and respiratory failure (Mandell & Read, 2010).

Diagnostic evaluation includes:

• Detailed clinical history and physical examination
• Pulmonary function testing such as spirometry
• Imaging modalities like chest X-rays and CT scans
• Microbiological analysis of sputum samples to detect causative organisms (Mahashur, 2018).

How Are Chronic Lower Respiratory Infections Treated?

Treatment aims to relieve symptoms, slow disease progression, and improve pulmonary function, tailored by condition type:

Condition	Treatment Approaches
COPD	Smoking cessation, inhaled bronchodilators, corticosteroids, pulmonary rehabilitation, and vaccinations (National Heart Lung and Blood Institute, 2023)
Bronchiectasis	Airway clearance techniques, targeted antibiotics, and immunizations
Chronic Pneumonia	Pathogen-specific antibiotic therapy, supportive care, and preventive vaccination (Mandell & Read, 2010)

What Feedback Was Received on the Synthesis?

Healthcare professionals reviewed the synthesis as clear, well-organized, and informative. The document thoroughly covered key elements like etiology, clinical signs, diagnostics, and treatments. No specific improvements were suggested, indicating the synthesis fulfilled its educational objectives effectively. Reviewers demonstrated comprehensive understanding by summarizing the disease characteristics accurately.

---

Phase 1C: GoReact Video Reflection Summary

The chronic lower respiratory infection synthesis was designed to provide healthcare professionals with a concise yet comprehensive educational tool. Drawing on clinical experience as a Medical-Surgical Telemetry nurse, the content was carefully researched and supported by authoritative references.

A significant challenge was condensing detailed clinical information into a single-page summary without omitting critical points. Peer feedback was overwhelmingly positive, emphasizing the clear and well-structured presentation that simplified complex concepts. The reviewers’ familiarity with the subject may have limited suggestions for further refinement, but their accurate articulation of key points reflected strong comprehension.

---

Phase 2.2B: Patient or Healthcare Consumer-Focused Synthesis

What Is a Stroke and What Are Its Types?

A stroke, also known as a cerebrovascular accident (CVA), occurs when blood flow to a part of the brain is interrupted, either by a blockage (ischemic stroke) or by a ruptured blood vessel (hemorrhagic stroke). This disruption leads to the death of brain cells due to oxygen deprivation (American Heart Association, 2021).

What Are the Signs and Symptoms?

Symptoms depend on the brain area affected but commonly include:

• Sudden weakness or numbness on one side of the body
• Speech difficulties
• Severe headache
• Loss of balance or coordination
• Visual disturbances

The F-A-S-T mnemonic (Facial drooping, Arm weakness, Speech difficulties, Time to call emergency services) helps in early recognition (National Institute of Neurological Disorders and Stroke [NINDS], n.d.).

How Is Stroke Diagnosed?

Diagnosis involves:

• Clinical assessment and medical history
• Imaging techniques such as CT or MRI to identify stroke type and location
• Blood tests to evaluate risk factors and causes (American Heart Association, 2021).

What Treatments Are Available?

Treatment aims to restore blood flow quickly and limit brain damage:

• Ischemic Stroke: Use of thrombolytic agents like tissue plasminogen activator (tPA) or mechanical clot retrieval.
• Hemorrhagic Stroke: Control of bleeding, reduction of brain pressure, and possibly surgery.
• Rehabilitation through physical, occupational, and speech therapy is vital for recovery.

What Preventive Measures Are Recommended?

Stroke prevention focuses on managing risk factors, including blood pressure control, healthy diet, smoking cessation, and physical activity (NINDS, n.d.).

What Feedback Did Healthcare Consumers Provide?

Healthcare consumers found the stroke synthesis clear and practical, appreciating guidance on recognizing symptoms and prompt action. They recommended highlighting key terms to improve retention. Their ability to summarize the information confirmed the effectiveness of this patient-focused educational resource.

---

Phase 2C: GoReact Video Reflection Summary

The stroke synthesis was tailored for healthcare consumers, with an emphasis on simplifying medical language. The main challenge was maintaining brevity while ensuring accessibility for non-medical readers.

Feedback was positive, particularly regarding clarity and conciseness. The suggestion to emphasize key terms supports better engagement and comprehension. This experience underscored the importance of adapting health education to the literacy levels of the target audience for maximum impact.

---

Phase 3: 3B Advanced Professional Nurse or Colleague Synthesis and Patient Treatment Plan

Case Overview: COPD Patient Ms. O’Connor

Ms. O’Connor is a 55-year-old woman with worsening COPD symptoms, including productive cough and bronchospasm. Despite nicotine replacement therapy, she continues to smoke 3–5 cigarettes daily. Spirometry shows forced expiratory volume in 1 second (FEV1) at 1.37 liters (49% of predicted). Her family history includes smoking-related illnesses, and she has gained significant weight over two years.

What Is COPD Pathophysiology?

COPD is a chronic inflammatory lung disease caused by inhaling harmful particles, which leads to airway narrowing, loss of lung elasticity, and air trapping (Agarwal et al., 2023). These changes result in symptoms like cough, breathlessness, and mucus production.

What Are the Common Signs and Symptoms?

COPD manifestations typically include:

• Dyspnea (shortness of breath)
• Chronic cough and wheezing
• Excess mucus production
• Decreased exercise tolerance
• Physical signs such as barrel chest, cyanosis, and finger clubbing (Agarwal et al., 2023).

How Is COPD Diagnosed?

Diagnosis involves:

• Clinical history and symptom assessment
• Pulmonary function tests including spirometry
• Imaging (chest X-ray and CT scans)
• Arterial blood gas measurements
• Screening for alpha-1 antitrypsin deficiency (Agarwal et al., 2023).

What Are the Treatment Options and Potential Medication Side Effects?

Treatment Type	Medication Examples	Purpose	Potential Side Effects
Bronchodilators	Short-acting: Albuterol	Relax airways	Tremors, tachycardia, headaches
	Long-acting: Tiotropium	Maintain airway openness	Dry mouth, cough
Inhaled Corticosteroids	Formoterol	Reduce airway inflammation	Oral thrush, hoarseness (use mouthwash)
Smoking Cessation	Bupropion	Support smoking cessation	Insomnia, dry mouth, tremors, seizure risk

Non-pharmacological interventions such as pulmonary rehabilitation and vaccinations are critical components of COPD management (Agarwal et al., 2023).

What Feedback Was Provided on the COPD Synthesis and Treatment Plan?

Colleagues commended the synthesis for its clarity, depth, and readability. The use of bold text to highlight key terms was particularly appreciated as it improved information retention. Participation in the Shadow Health simulation enhanced clinical knowledge, assessment skills, and confidence in COPD management. This reinforced the importance of effective patient education in improving outcomes.

---

References

Agarwal, A. K., Raja, A., & Brown, B. D. (2023, August 7). Chronic obstructive pulmonary disease. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK559281/

American Heart Association. (2021). About stroke. American Stroke Association. https://www.stroke.org/en/about-stroke

Mahashur, A. (2018). Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin. Lung India, 35(2), 143–149. https://doi.org/10.4103/lungindia.lungindia_262_17

Mandell, L. A., & Read, R. C. (2010). Infections of the lower respiratory tract. In Antibiotic and Chemotherapy (pp. 574–588). https://doi.org/10.1016/B978-0-7020-4064-1.00045-2

National Heart Lung and Blood Institute. (2023). Treatment. https://www.nhlbi.nih.gov/health/copd/treatment

National Institute of Neurological Disorders and Stroke. (n.d.). Signs and symptoms. https://www.ninds.nih.gov/health-information/stroke/signs-and-symptoms

National Institute of Neurological Disorders and Stroke. (n.d.). Assess and treat. https://www.ninds.nih.gov/health-information/stroke/assess-and-treat

National Institute of Neurological Disorders and Stroke. (n.d.). Prevention. https://www.ninds.nih.gov/health-information/stroke/prevention

U.S. National Library of Medicine. (n.d.). Albuterol oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a682145.html

D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries

U.S. National Library of Medicine. (n.d.). Tiotropium oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a604018.html

U.S. National Library of Medicine. (n.d.-c). Formoterol oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a602023.html

U.S. National Library of Medicine. (n.d.). Bupropion: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a695033.html

Wheeldon, A. (2023). The respiratory system and associated disorders. British Journal of Nursing, 32(13), 613–619. https://doi.org/10.12968/bjon.2023.32.13.613

World Health Organization (WHO). (2017). Chronic obstructive pulmonary disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)

The post D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries appeared first on NURSFPX.com.